| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830270507 |
| P698 | PubMed publication ID | 9174596 |
| P2093 | author name string | Park W | |
| Schmidt D | |||
| Weyand CM | |||
| Goronzy JJ | |||
| P2860 | cites work | Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation | Q24311763 |
| Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor | Q24315230 | ||
| CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF | Q24316162 | ||
| A novel receptor involved in T-cell activation | Q24319016 | ||
| Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor | Q24319938 | ||
| CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones | Q28209894 | ||
| The role of the CD28 receptor during T cell responses to antigen | Q28263234 | ||
| Heat-stable antigen is a costimulatory molecule for CD4 T cell growth | Q28508401 | ||
| CD43 is a murine T cell costimulatory receptor that functions independently of CD28 | Q28586182 | ||
| Differential T cell costimulatory requirements in CD28-deficient mice | Q28590647 | ||
| Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor | Q28594006 | ||
| T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. | Q33658811 | ||
| Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis | Q34158788 | ||
| Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule | Q34298838 | ||
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease | Q35604700 | ||
| Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. | Q36230408 | ||
| Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation | Q36231212 | ||
| Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo | Q36353340 | ||
| Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor | Q36355375 | ||
| B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance | Q36362561 | ||
| Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". | Q36362764 | ||
| "Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype | Q36362774 | ||
| B70 antigen is a second ligand for CTLA-4 and CD28 | Q36697598 | ||
| Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells | Q36726518 | ||
| CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity | Q37354502 | ||
| Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy | Q38624477 | ||
| Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance | Q40396698 | ||
| Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor | Q41429389 | ||
| Transactivation by AP-1 is a molecular target of T cell clonal anergy | Q41607885 | ||
| Fas transduces activation signals in normal human T lymphocytes | Q41906015 | ||
| T cell receptor V beta repertoire of double-negative alpha/beta T cells in patients with systemic sclerosis | Q42041600 | ||
| Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings | Q42631372 | ||
| Absence of B7-dependent responses in CD28-deficient mice | Q56909633 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1082-1090 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells | |
| P478 | volume | 27 |
| Q34106843 | Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity |
| Q47943623 | Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells. |
| Q73864113 | Altered expression of costimulatory molecules in myasthenia gravis |
| Q33915352 | Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation |
| Q51871199 | Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. |
| Q24807037 | Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q56907492 | Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells |
| Q34474734 | DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis |
| Q37454068 | Developments in the scientific understanding of rheumatoid arthritis |
| Q77369797 | Does the distribution of circulating CD4+CD28+, CD4+CD25+ T lymphocytes indicate subclinical rejection in patients in the early postoperative state of renal transplantation? |
| Q79137043 | Expansion of peripheral CD8+ T cells in patients with coronary artery disease: relation to cytomegalovirus infection |
| Q47776925 | Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis |
| Q42495629 | Functional disruption of the CD28 gene transcriptional initiator in senescent T cells |
| Q77162637 | Functional properties of CD4+ CD28- T cells in the aging immune system |
| Q77627706 | Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes |
| Q39444602 | High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity. |
| Q83316131 | Human thymic stromal lymphopoietin enhances expression of CD80 in human CD14+ monocytes/macrophages |
| Q34777989 | Immune aging and autoimmunity |
| Q77628789 | Involvement of CD4+,CD57+ T cells in the disease activity of rheumatoid arthritis |
| Q38676903 | Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal? |
| Q64108180 | Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response |
| Q33782717 | Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics |
| Q35748061 | Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis |
| Q36152969 | Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers |
| Q36735976 | Perturbation of the T cell repertoire in rheumatoid arthritis |
| Q24797697 | Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis |
| Q27693905 | Rheumatoid Arthritis: A Role for Immunosenescence? |
| Q37892982 | Role of unusual CD4+ CD28- T cells in acute coronary syndrome |
| Q24804863 | The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis |
| Q61945657 | The expansion of CD4+CD28− t cells in patients with chronic kidney graft rejection |
| Q28082856 | The story of CD4+ CD28- T cells revisited: solved or still ongoing? |
| Q61946763 | Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritis |
| Q35849700 | Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. |
Search more.